IRIS
CELLERINO, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.365
Totale 2.365
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 2.365
Totale 2.365
Salva come PNG Salva come JPEG
Città #
Genova 911
Genoa 642
Vado Ligure 412
Rapallo 389
Bordighera 11
Totale 2.365
Salva come PNG Salva come JPEG
Nome #
Osteopathic Manipulative Therapy and Multiple Sclerosis: A Proof-of-Concept Study 136
Retinal degeneration in primary-progressive multiple sclerosis: A role for cortical lesions? 135
Different MRI patterns in MS worsening after stopping fingolimod 135
Levodopa-induced neutropenia. 128
Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS 117
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 113
A novel prion protein gene-truncating mutation causing autonomic neuropathy and diarrhea 106
Homonymous hemianopia as the first sign of posterior cortical atrophy 93
Pediatric optic neuritis and anti MOG antibodies: a cohort of Italian patients 76
Corneal epithelial dendritic cells in patients with multiple sclerosis: An in vivo confocal microscopy study 76
Impact of treatment on cellular immunophenotype in MS: A cross-sectional study 71
Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS Population 66
Neuroaxonal Degeneration in Patients With Multiple Sclerosis: An Optical Coherence Tomography and in Vivo Corneal Confocal Microscopy Study 65
Assessing upper limb function in Multiple Sclerosis by an engineered glove 63
COVID-19 pandemic and mental distress in Multiple Sclerosis: implications for clinical management 60
Severe disease activity in MS patients treated with cladribine after fingolimod withdrawal 59
Corneal sub-basal nerve plexus analysis in patients with multiple sclerosis 54
Risk of Persistent Disability in Patients with Pediatric-Onset Multiple Sclerosis 48
Tailoring B cell depletion therapy in MS according to memory B cell monitoring 47
Anti-SARS-CoV-2 monoclonal antibodies for the treatment of active COVID-19 in multiple sclerosis: An observational study 46
Choroidal Thickness in Multiple Sclerosis: An Optical Coherence Tomography Study 45
Clinical and radiological correlates of apathy in multiple sclerosis 44
The early effect of cladribrine versus fingolimod on clinical and MRI measures in relapsing remitting multiple sclerosis 42
In-vivo characterization of macro- and microstructural injury of the subventricular zone in relapsing-remitting and progressive multiple sclerosis 41
Relationship Between Retinal Layer Thickness and Disability Worsening in Relapsing-Remitting and Progressive Multiple Sclerosis 40
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab 38
Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis 37
CD19+ B cell values predict the increase of anti-SARS CoV2 antibodies in fingolimod-treated and COVID-19-vaccinated patients with multiple sclerosis 36
Embracing resilience in multiple sclerosis: a new perspective from COVID-19 pandemic 36
Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic? 32
Central vein sign and diffusion MRI differentiate microstructural features within white matter lesions of multiple sclerosis patients with comorbidities 31
What happens after fingolimod discontinuation? A multicentre real-life experience 30
Evaluating the central vein sign in paediatric-onset multiple sclerosis: A case series study 28
The role of disconnection in explaining disability in multiple sclerosis 27
Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration 27
Physical exercise moderates the effects of disability on depression in people with multiple sclerosis during the covid-19 outbreak 21
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis 20
null 20
The effect of Cladribine and Fingolimod treatments on retinal atrophy 19
Vaccinations in patients with multiple sclerosis: a real-world, single-center experience 19
EXPLORING THE INTERACTION BETWEEN FOCAL INFLAMMATION AND AXONAL INJURY IN MULTIPLE SCELROSIS: A NEW MECHANISM-DRIVEN FRAMEWORK TO MONITOR DISEASE ACTIVITY AND PROGRESSION 17
Multiscale networks in multiple sclerosis 17
Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial 16
Effect of ocrelizumab treatment on retinal atrophy: preliminary results from a single-center observational study 14
Predicting disease severity in Multiple Sclerosis using multimodal data and machine learning 14
Erratum: Choroidal Thickness in Multiple Sclerosis: An Optical Coherence Tomography Study 12
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic 12
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy 11
Brain lesion microstructure in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein disease 10
Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian study 6
Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis 5
Lesion phenotyping based on magnetic susceptibility in pediatric multiple sclerosis 5
ELEVATED RISK OF THROMBOTIC MANIFESTATIONS OF SARS-COV-2 INFECTION IN CANCER PATIENTS: A LITERATURE REVIEW 5
Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factors 4
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study 3
Individual Prognostication of Disease Activity and Disability Worsening in Multiple Sclerosis With Retinal Layer Thickness z Scores 3
Tissue factor as a potential coagulative/vascular marker in relapsing-remitting multiple sclerosis 3
On the Assessment of Gray Code Kernels for Motion Characterization in People with Multiple Sclerosis: A Preliminary Study 3
Safety of anti-varicella zoster virus vaccination in patients with multiple sclerosis treated with natalizumab: A case series 3
Brain disconnectome mapping derived from white matter lesions and serum neurofilament light levels in multiple sclerosis: A longitudinal multicenter study 2
Totale 2.492
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.751
article - articoli 12.289
book - libri 0
conference - conferenze 360
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 9
Totale 25.409
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020326 0 0 0 0 41 53 56 36 44 51 34 11
2020/2021229 11 15 23 36 24 20 11 18 18 36 7 10
2021/2022253 9 4 5 21 13 19 4 55 24 41 9 49
2022/2023469 34 44 11 51 52 62 4 33 77 4 77 20
2023/2024556 20 42 16 58 34 66 156 24 24 26 30 60
2024/2025487 87 105 64 102 129 0 0 0 0 0 0 0
Totale 2.492